Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sorich

Showing results (41-50 of 216) with videos related to

Pageof 22
Sort By:
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 26, 2011
A review of candidate urinary biomarkers for autism spectrum disorderLv Wang, Manya T Angley, Jacobus P Gerber, et al.
The AAPS Journal|June 21, 2019
Guidance for Rifampin and Midazolam Dosing Protocols To Study Intestinal and Hepatic Cytochrome P450 (CYP) 3A4 Induction and De-inductionAsha J Kapetas, Michael J Sorich, A David Rodrigues, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2019
Author's ReplyMichael J Sorich, Andrew Rowland, Christos S Karapetis, et al.
Pharmacoeconomics|April 10, 2013
Review of the cost effectiveness of pharmacogenetic-guided treatment of hypercholesterolaemiaMichael J Sorich, Michael D Wiese, Rebekah L O'Shea, et al.
Therapeutic Advances in Drug Safety|October 20, 2015
Pharmacists in Australian general practice: an opportunity for expertise in precision medicineThomas M Polasek, Andrew Rowland, Michael D Wiese, et al.
Pharmacogenomics|September 17, 2016
Pharmacogenetic and ethnicity influence on oxaliplatin therapy for colorectal cancer: a meta-analysisAdel Shahnam, Zainab Ridha, Michael D Wiese, et al.
Journal of Medicinal Chemistry|April 18, 2003
Pharmacophore and quantitative structure-activity relationship modeling: complementary approaches for the rationalization and prediction of UDP-glucuronosyltransferase 1A4 substrate selectivityPaul A Smith, Michael J Sorich, Ross A McKinnon, et al.
Molecular Pharmacology|January 27, 2004
Multiple pharmacophores for the investigation of human UDP-glucuronosyltransferase isoform substrate selectivityMichael J Sorich, John O Miners, Ross A McKinnon, et al.
JAMA Internal Medicine|November 13, 2023
Health Disinformation Use Case Highlighting the Urgent Need for Artificial Intelligence Vigilance: Weapons of Mass DisinformationBradley D Menz, Natansh D Modi, Michael J Sorich, et al.
Journal of Chemical Information and Modeling|November 28, 2006
The importance of local chemical structure for chemical metabolism by human uridine 5'-diphosphate-glucuronosyltransferaseMichael J Sorich, Ross A McKinnon, John O Miners, et al.
Pageof 22

Showing results (41-50 of 216) with videos related to

Sort By:
Pageof 22
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 26, 2011
A review of candidate urinary biomarkers for autism spectrum disorderLv Wang, Manya T Angley, Jacobus P Gerber, et al.
The AAPS Journal|June 21, 2019
Guidance for Rifampin and Midazolam Dosing Protocols To Study Intestinal and Hepatic Cytochrome P450 (CYP) 3A4 Induction and De-inductionAsha J Kapetas, Michael J Sorich, A David Rodrigues, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2019
Author's ReplyMichael J Sorich, Andrew Rowland, Christos S Karapetis, et al.
Pharmacoeconomics|April 10, 2013
Review of the cost effectiveness of pharmacogenetic-guided treatment of hypercholesterolaemiaMichael J Sorich, Michael D Wiese, Rebekah L O'Shea, et al.
Therapeutic Advances in Drug Safety|October 20, 2015
Pharmacists in Australian general practice: an opportunity for expertise in precision medicineThomas M Polasek, Andrew Rowland, Michael D Wiese, et al.
Pharmacogenomics|September 17, 2016
Pharmacogenetic and ethnicity influence on oxaliplatin therapy for colorectal cancer: a meta-analysisAdel Shahnam, Zainab Ridha, Michael D Wiese, et al.
Journal of Medicinal Chemistry|April 18, 2003
Pharmacophore and quantitative structure-activity relationship modeling: complementary approaches for the rationalization and prediction of UDP-glucuronosyltransferase 1A4 substrate selectivityPaul A Smith, Michael J Sorich, Ross A McKinnon, et al.
Molecular Pharmacology|January 27, 2004
Multiple pharmacophores for the investigation of human UDP-glucuronosyltransferase isoform substrate selectivityMichael J Sorich, John O Miners, Ross A McKinnon, et al.
JAMA Internal Medicine|November 13, 2023
Health Disinformation Use Case Highlighting the Urgent Need for Artificial Intelligence Vigilance: Weapons of Mass DisinformationBradley D Menz, Natansh D Modi, Michael J Sorich, et al.
Journal of Chemical Information and Modeling|November 28, 2006
The importance of local chemical structure for chemical metabolism by human uridine 5'-diphosphate-glucuronosyltransferaseMichael J Sorich, Ross A McKinnon, John O Miners, et al.
Pageof 22